Table 2.
COST Values, Willingness to Discuss Costs, and Clinical Trial Status
| N = 233 | COST (Mean ± SD) | Univariable P | |
|---|---|---|---|
| Willing to discuss costs with care team | |||
| Yes | 106 (45.5%) | 22.54 ± 12.41 | .49 |
| No or unsure | 105 (45.1%) | 21.42 ± 11.28 | |
| Clinical trial status | |||
| Yes | 65 (27.9%) | 23.26 ± 11.92 | .41 |
| No | 168 (72.1%) | 21.84 ± 11.89 | |
Abbreviations: COST, COmprehensive Score for financial Toxicity; SD, standard deviation.
Some percentages do not add to 100% due to missing data. Univariate P values were derived from linear regression models. Lower COST values indicate higher toxicity.